Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Jul 2026 for ADC Therapeutics SA. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Peter J. Graham: trading record in brief
This profile gathers the share dealings of Peter J. Graham across 2 companies, led by ADC Therapeutics SA and Antares Pharma, Inc. The record holds 10 filings, for trades running from 8 June 2021 to 30 June 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 2 July 2026: a share grant, in ADC Therapeutics SA. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Peter J. Graham
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
221,100 sharesCommon SharesSEC:0001628280-26-047034:0
294,800 shares@ US$3.9962.2% of flowCommon SharesSEC:0001628280-26-009280:0
49,508 shares@ US$3.2923.2% of flowCommon SharesSEC:0001628280-25-056169:0
220,000 shares@ US$1.6156.5% of flowCommon SharesSEC:0001628280-25-005863:0
41,458 shares@ US$3.1320.3% of flowCommon SharesSEC:0001628280-24-050540:0
414,470 shares@ US$5.6074.5% of flowCommon StockSEC:0000899243-22-019789:0
26,044 shares0Common StockSEC:0001016169-22-000031:0
23,068 shares0Common StockSEC:0001016169-22-000016:0
85,973 shares@ US$4.4212.3% of flowCommon StockSEC:0001209191-21-040328:0
15,996 shares@ US$4.392.3% of flowCommon StockSEC:0001209191-21-039591:0
10 of 10 declarations
